CGRP and Painful Pathologies Other than Headache

Area of Science:

• Neuroscience
• Rheumatology
• Pain Research

Background:

• Calcitonin gene-related peptide (CGRP) has been implicated in pain signaling.
• Evidence linking CGRP to musculoskeletal pain is largely circumstantial.
• CGRP's role in conditions other than migraine requires further elucidation.

Purpose of the Study:

• To comprehensively review the evidence for CGRP's association with musculoskeletal pain.
• To summarize evidence supporting CGRP as a direct cause of pain in various conditions.
• To explore CGRP's potential as a pain biomarker in musculoskeletal disorders.

Main Methods:

• Review of existing literature on CGRP and pain.
• Analysis of studies on CGRP-immunoreactive nerves in musculoskeletal tissues.
• Examination of research on altered CGRP expression in musculoskeletal pain states.
• Inclusion of human observational studies, animal arthritis models, and randomized controlled trials of CGRP-targeting treatments.

Main Results:

• CGRP-immunoreactive nerves are found within musculoskeletal tissues.
• CGRP expression levels are altered in the presence of musculoskeletal pain.
• CGRP influences musculoskeletal pain through peripheral and central nervous system mechanisms.

Conclusions:

• CGRP is a significant factor in musculoskeletal pain modulation.
• The evidence supports CGRP's role as a potential pain biomarker.
• CGRP's involvement in pain extends to conditions beyond migraine.